在精密切割的肺切片中以小RNA为基础的配方 - - 对体内/体外研究有其他选择吗?
Joanna Nowakowska-Lewicka1,2, Aleksandra Szczepankiewicz1,3
1Poznan University of Medical Sciences, Molecular and Cell Biology Unit, Department of Pediatric Pulmonology, Allergy and Clinical Immunology, Poznan, Poland.
Expert review of respiratory medicine
|December 5, 2025
概括
精密切割的肺切片 (PCLS) 为研究非编码RNA疗法提供了有价值的体外模型. 输送方法的标准化和疗效评估对于推进PCLS模型中基于RNA的药物开发至关重要.
科学领域:
- * 肺部研究研究
- * 活体肺部模型
- *基于RNA的治疗方法
背景情况:
- *精密切割的肺切片 (PCLS) 是研究肺部疾病的先进体外模型.
- *PCLS保留了多样化的细胞类型和细胞外基质,使其成为研究非编码RNA等治疗性小分子的理想选择.
- * 非编码RNAs,包括微RNAs (miRNAs) 和小干扰RNAs (siRNAs),显示肺部疾病的治疗潜力.
研究的目的:
- * 通过使用PCLS模型审查当前的miRNA和siRNA研究.
- * 评估PCLS中基于RNA的输送策略的治疗潜力.
- * 确定基于PCLS的RNA研究的方法挑战和改进领域.
主要方法:
- *对使用PCLS用于miRNA和siRNA研究的研究进行了全面的文献综述.
- * 在PCLS中分析RNA/miRNA分离技术.
- * 检查各种方法来将miRNA和siRNA输送到PCLS.
主要成果:
- *PCLS是小型RNA药物递送系统研究的一个有前途的平台.
- * 目前的研究强调需要标准化方法来评估RNA和蛋白质水平的转染疗效.
- *在研究中观察到传染效率和生物效应的报告不一致.
结论:
- * 实验标准和方法的标准化对于PCLS模型中的可重复结果至关重要.
- *未来的研究应该纳入更多独立的复制品和多样化的方法,以提高PCLS研究的可靠性.
- *解决PCLS切片中的异质性是提高发现有效性的关键.
相关概念视频
Experimental RNAi
7.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.2K
RNA Interference
27.7K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
27.7K
siRNA - Small Interfering RNAs
18.3K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.3K


